In Vitro Diagnostics Alliances / In Vitro Diagnostics Genomic Health Inc. Genomic Health (oncogenomics diagnostics) netted $43.3mm through the follow-on public offering of 3mm common shares at $15.
Automated medium- and high-throughput ion channel screening systems promise to jump start the search for ion channel modulating drugs, a vast and promising area of drug discovery. In Vivo Europe Rx lo
Drug design for complex receptor targets 1030 Hull Street Cascade Building, Suite 300 Baltimore, MD 21230 Phone: (410) 752-9310 Fax: (410) 752-9315 Web Site: www.receptorbase.com Contact: Gary A. St